PepsiCo's Ethiopian Expansion and GLP-1 Headwinds Collide on a Stock Seeking Its Footing
Published on 09/23/2026 at 15:20 | Editorial boerse-global.de
PepsiCo is pressing ahead with a major capacity buildout in East Africa while simultaneously navigating a far more complicated demand picture at home, where the rise of GLP-1 weight-loss drugs is forcing the snack and beverage giant to rethink both its brand exposure and its employee benefits.
The company's stock changed hands at EUR 115.60 in German trading, showing tentative signs of stabilization after recent declines. That level sits 3.7% above the 52-week low of EUR 111.52.
A Tenfold Bet on Ethiopian Snacks
The centerpiece of PepsiCo's African ambitions is a capital injection equivalent to roughly two billion Ethiopian birr, earmarked for its existing Senselet facility located about 65 kilometers from Addis Ababa. The plan calls for adding a production line for potato chips and snacks, including products sold under the SUN Chips banner.
The expansion is designed to multiply local snack output tenfold. It would also add more than 500 jobs to a workforce that currently numbers over 150. The agreement still hinges on regulatory approvals and investment incentives before it can move forward.
Packaging Alliance Takes Shape
Running parallel to the regional push, PepsiCo is helping reshape industry packaging standards. The company has joined an initiative convened by the Ellen MacArthur Foundation alongside Nestlé, Unilever and Procter & Gamble. The group is working to develop paper-based, recyclable alternatives to flexible plastic packaging. Joint testing will explore biodegradable coatings capable of preserving product protection and shelf life, with a focus on markets where plastic use is heavy and collection and recycling infrastructure remains inadequate.
Should investors sell immediately? Or is it worth buying PepsiCo?
GLP-1 Drugs Reshape the Risk Map
Back on the demand side, the global spread of appetite-suppressing medications is drawing sharper scrutiny to PepsiCo's brand portfolio. Research from Brand Finance puts roughly USD 73 billion of brand value across the global food sector at risk from growing GLP-1 usage.
For PepsiCo specifically, the Lay's potato chip brand sits at the center of that concern, with USD 6.8 billion in brand value flagged as threatened. Across all of the company's snack brands, the analysis identifies USD 14.1 billion as exposed.
The pressure is also being felt internally. According to Bloomberg News, PepsiCo is among the large employers moving to drop GLP-1 medications from company-funded supplemental insurance plans for workers, as the cost of those treatments climbs rapidly.
Valuation and Yield Offer a Cushion
Offsetting the demand-side headwinds is a historically modest valuation. A price-to-earnings ratio of around 17 and a dividend yield near 4.5% keep the shares relevant for conservative investors. Reliability is the core selling point: PepsiCo has raised its payout for 54 consecutive years.
That backdrop is shifting how market participants view the stock — away from pure defensive merit and toward questions about whether the portfolio can adapt. Steady dividend payments can soften drawdowns, but without a durable turnaround in sales volumes, a meaningful re-rating may prove elusive.
Europe Adds Friction
While the company hunts for growth in East Africa, the operating environment in parts of Europe remains strained. Higher distribution expenses and exceptional supplier charges weighed on results at the Greek unit. Management in the region expects continued pressure from raw material, energy and transport costs through the current year.
Investors are now looking to upcoming interim reports for clearer signals of a technical bottom. How convincingly PepsiCo answers the shift in consumer health consciousness will shape what comes next. Until then, the shares remain a balancing act between a dependable payout and lingering doubts about the traditional snack business.
Ad
PepsiCo Stock: New Analysis - 23 September
Fresh PepsiCo information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
